COVID-19 offers an endless array of research options as researchers scramble to understand everything from its adaptation in humans to the leftover effects of the disease in what we call “long-haulers”. This latter topic of “long-haulers” forced upon us by this virus takes center stage in the article of interests as King’s College London researchers believe they can explain why some patients suffer from “long COVID”.
COVID risks and risks of COVID might sum up today’s post, highlighting the possible two-way street between this coronavirus pandemic and autoimmunity diseases. Two questions have arisen from the COVID 19 pandemic. First, who is at risk? Second, after the infection is over what problems are left behind? Autoimmunity, or the condition where our bodies attack themselves finds itself in the hot seat for both of these critical questions.